Sample processing obscures cancer-specific alterations in leukemic transcriptomes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 47, 2014, Pages 16802-16807

  Dvinge, Heidi ^a   Ries, Rhonda E ^a   Ilagan, Janine O ^a   Stirewalt, Derek L ^a   Meshinchi, Soheil ^a,b   Bradley, Robert K ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Batch effects; Leukemia; Nonsense mediated decay; RNA splicing

Indexed keywords

COMPLEMENTARY RNA; TRANSCRIPTOME; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; B LYMPHOCYTE; CANCER GENETICS; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOCYTE ACTIVATION; NONSENSE MEDIATED MRNA DECAY; PERIPHERAL BLOOD MONONUCLEAR CELL; PSEUDOGENE; RNA SPLICING; T LYMPHOCYTE; GENETICS; HUMAN GENOME; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

GENOME, HUMAN; HUMANS; LEUKEMIA; LYMPHOCYTE ACTIVATION; NF-KAPPA B; RNA SPLICING; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84913534661     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1413374111     Document Type: Article

References (35)

1. Leek JT, et al. (2010) Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet 11(10):733-739
2. Chen C, et al. (2011) Removing batch effects in analysis of expression microarray data: An evaluation of six batch adjustment methods. PLoS ONE 6(2):e17238
3. Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8(1):118-127
4. Scharpf RB, et al. (2011) A multilevel model to address batch effects in copy number estimation using SNP arrays. Biostatistics 12(1):33-50
5. Li S, et al. (2014) Detecting and correcting systematic variation in large-scale RNA sequencing data. Nat Biotechnol 32(9):888-895
6. Bowen RA, Remaley AT (2014) Interferences from blood collection tube components on clinical chemistry assays. Biochem Med (Zagreb) 24(1):31-44
7. Tammen H (2008) Specimen collection and handling: Standardization of blood sample collection. Methods Mol Biol 428:35-42
8. Gillio-Meina C, Cepinskas G, Cecchini EL, Fraser DD (2013) Translational research in pediatrics II: Blood collection, processing, shipping, and storage. Pediatrics 131(4): 754-766
9. Rainen L, et al. (2002) Stabilization of mRNA expression in whole blood samples. Clin Chem 48(11):1883-1890
10. Liu Y, Malaviarachchi P, Beggs M, Emanuel PD (2010) PTEN transcript variants caused by illegitimate splicing in "aged" blood samples and EBV-transformed cell lines. Hum Genet 128(6):609-614
11. Thomson SA, Wallace MR (2002) RT-PCR splicing analysis of the NF1 open reading frame. Hum Genet 110(5):495-502
12. Birrell GW, Ramsay JR, Tung JJ, Lavin MF (2001) Exon skipping in the ATM gene in normal individuals: The effect of blood sample storage on RT-PCR analysis. Hum Mutat 17(1):75-76
13. Barnes MG, Grom AA, Griffin TA, Colbert RA, Thompson SD (2010) Gene expression profiles from peripheral blood mononuclear cells are sensitive to short processing delays. Biopreservation Biobanking 8(3):153-162
14. Salway F, Day PJ, Ollier WE, Peakman TC (2008) Levels of 5' RNA tags in plasma and buffy coat from EDTA blood increase with time. Int J Epidemiol 37(suppl 1):i11-i15
15. Baechler EC, et al. (2004) Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun 5(5):347-353
16. Adamia S, et al. (2014) NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): New potential targets in AML. Blood 123(18):2816-2825
17. Kühnl A, et al. (2011) Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. Blood 118(24):6362-6367
18. Metzeler KH, et al. (2012) High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia. Blood 120(10):2118-2126
19. Zhang T, et al. (2013) PHF20 regulates NF-?B signalling by disrupting recruitment of PP2A to p65. Nat Commun 4:2062
20. Meyer JA, et al. (2013) Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nat Genet 45(3):290-294
21. Quesada V, et al. (2012) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44(1):47-52
22. Macrae T, et al. (2013) RNA-Seq reveals spliceosome and proteasome genes as most consistent transcripts in human cancer cells. PLoS ONE 8(9):e72884
23. Atak ZK, et al. (2013) Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia. PLoS Genet 9(12):e1003997
24. Cancer Genome Atlas Research Network (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368(22):2059-2074.
25. McNerney ME, et al. (2013) CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood 121(6): 975-983
26. Wen H, et al. (2012) New fusion transcripts identified in normal karyotype acute myeloid leukemia. PLoS ONE 7(12):e51203
27. Piazza R, et al. (2013) Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet 45(1):18-24
28. Stirewalt DL, et al. (2008) Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosomes Cancer 47(1):8-20
29. Schmitz R, et al. (2012) Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490(7418):116-120
30. Morin RD, et al. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476(7360):298-303
31. Ferreira PG, et al. (2014) Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res 24(2):212-226
32. Meyer LR, et al. (2013) The UCSC Genome Browser database: Extensions and updates 2013. Nucleic Acids Res 41(database issue):D64-D69
33. Müller MC, et al. (2002) Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization. Leukemia 16(12):2395-2399
34. Gallego Romero I, Pai AA, Tung J, Gilad Y (2014) RNA-seq: Impact of RNA degradation on transcript quantification. BMC Biol 12(1):42
35. Gardner LB (2010) Nonsense-mediated RNA decay regulation by cellular stress: Implications for tumorigenesis. Mol Cancer Res 8(3):295-308